Compass Financial Group, Inc. Johnson & Johnson Transaction History

Compass Financial Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$151.05 - $180.26 $5,890 - $7,030	-39 Reduced 2.85%	1,329 $206,000
Q3 2022 Nov 09, 2022	BUY	$161.33 - $179.52 $21,618 - $24,055	134 Added 10.86%	1,368 $223,000
Q4 2021 Feb 07, 2022	SELL	$155.93 - $173.01 $17,776 - $19,723	-114 Reduced 8.46%	1,234 $211,000
Q2 2021 Aug 03, 2021	BUY	$159.48 - $171.07 $18,180 - $19,501	114 Added 9.24%	1,348 $222,000
Q1 2021 May 05, 2021	BUY	$153.07 - $170.48 $188,888 - $210,372	1,234 New	1,234 $203,000

4,272

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Compass Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Compass Financial Group, Inc. with notifications on news.